Lok S S, Smith E, Doran H M, Sawyer R, Yonan N, Egan J J
North West Lung Centre, Wythenshawe Hospital, Manchester, United Kingdom.
Chest. 1998 Nov;114(5):1478-81. doi: 10.1378/chest.114.5.1478.
Idiopathic pulmonary fibrosis (IPF) has a poor prognosis and therapeutic options are limited with a 5-year survival of less than 50%. This report includes a case of histologically confirmed IPF in a patient whose native lung showed objective improvement as measured by high-resolution CT while he was receiving cyclosporine-based immunosuppressive therapy after single-lung transplantation.